Semaglutide effects include weight loss and common stomach trouble.

Studies found harm that patient stories can’t prove

Studies give the firmer answer because they compare Semaglutide users with another group getting other care or a placebo, then track both groups over the same span of time. That’s the stronger proof.

A placebo has no Semaglutide but looks like the treatment. That comparison helps show which changes came from the drug.

Patient reports don’t give the same kind of proof. They tell you what users noticed, but can’t prove the cause.

The studies found stomach trouble most often. They also found gallstones, lost muscle, and weight returning after treatment ended.

Many patients say they think about food less. They also say a smaller meal fills them.

Nausea, burping, loose stools, and constipation lead their complaints. The trouble often begins when the amount rises.

This page doesn’t tell you to start or stop. That choice belongs in a talk with your doctor.

Patient stories can’t forecast how your body will respond. They’ll prepare you for topics to raise at that visit.

Patients describe less hunger and plenty of stomach trouble

These notes come from people who’ve taken Semaglutide. These are personal reports about what patients noticed. Comparison studies didn’t prove the claims.

Your body may respond quite differently. You won’t find personal dose advice here.

Help that people mention most:

• Food stays off their mind: People say thoughts of food no longer crowd the day. Many feel full sooner and quit planning the next meal.

• Cravings lose strength: Greasy food and sweets may stop looking good. Some patients say lighter meals become easier to choose.

• Weight comes down: Most patients report losing weight over several months. They often tie the change to eating less.

• Blood sugar gets better: People with type 2 diabetes say their blood tests improve. Some say morning readings return to the range their doctor wants.

• Alcohol seems less tempting: Some people say they don’t want a drink. Food cravings may ease at the same time.

Trouble that people mention most:

• Nausea comes first: Roughly a third of patients mention nausea, and some vomit. It’s often worse early or when the amount goes up.

• Burps may taste foul: People compare the taste with eggs or sulfur. A swollen belly and slow digestion may come along.

• Bowel habits may swing: Patients report diarrhea and constipation. Eating much less can make constipation worse.

• Heartburn may flare: Some people report heartburn, burping, and bloating at the same time. The trouble may start when the dose rises.

• Tiredness may come early: The first two days after a shot can leave some people worn out. Many report better energy later.

• Food may seem strange: Some patients say food has a metal taste or seems unpleasant. A few set reminders for meals.

• Headaches or dizziness may occur: People often blame not eating or drinking enough. Some felt better after drinking more water.

• The shot area may get sore: Patients report brief redness, itching, or a small bump. The skin often settles soon.

These reports can’t tell what you’ll feel. They’ll help you name a change when you call your doctor.

Semaglutide hair loss may be tied to fast weight change

Some patients notice more shedding months into treatment. Patients say this happened; the comparison studies didn’t test the claim.

Some also see a thinner face. Both changes may come from fast weight loss instead of the drug itself.

One review found more hair-loss reports with Semaglutide ^[19]. It didn’t show that the medicine harmed hair roots.

A skin study linked fast weight loss with short-term shedding across the scalp ^[20]. Hair often returns as the body settles.

Fast loss fits the known facts best. Direct damage from the drug hasn’t been shown.

A report can’t explain why your hair is shedding. Your doctor can check for illness, poor diet, or another cause.

The warnings also cover the thyroid, pancreas, eyes, gallstones, and muscle

These cautions come from studies and safety reviews. They aren’t patient stories.

• Stomach trouble comes first. Nausea, vomiting, diarrhea, and constipation made some people quit, though the trouble was usually mild and short ^[13].

Nausea affected roughly one person in three in another safety review ^[5]. Reports gathered after FDA approval also put stomach trouble first ^[14].

• A rare thyroid cancer in your family matters. The FDA gives its strongest warning to this family of GLP-1 drugs, which copy a gut hormone.

The warning also names an inherited illness called MEN-2. It’s an illness that raises tumor risk in several glands.

Mice and rats developed tumors after getting large drug amounts. Human studies haven’t shown that same harm at the amounts people receive.

In 2024, a review couldn’t find a rise in thyroid cancer among people ^[15], but doctors still avoid the drug when that illness runs in the family ^[5].

• Pancreatitis is another warning. Pancreatitis is sudden, painful swelling of your pancreas.

Doctors often stop treatment if they suspect that swelling. The review couldn’t settle whether pancreas cancer risk rose ^[5].

There weren’t enough cases for a firm answer. That doubt remains.

• Gallstones happened more often. A quick drop in weight may account for much of the rise, but the study still found more gallstones ^[5].

• A fast blood-sugar drop may hurt your eyes. SUSTAIN-6 found more eye trouble in patients whose diabetes had already harmed their eyes ^[2].

The 95% check made luck an unlikely answer for that extra trouble. Your doctor may watch your eyes more closely when sugar falls fast ^[5].

• The pounds lost included muscle. A weight study measured fat and muscle among the lost pounds ^[16].

The study didn’t test whether those people later became weak or frail, so doctors remain concerned about lost strength in older patients even though later harm isn’t proved yet. No study here answered that question.

• Weight came back once the medicine ended. In STEP 1, people regained weight equal to 11.6 percent of their starting weight within a year ^[17].

Their blood-sugar readings and signs tied to heart health also moved toward where they began. STEP 4 found the same after people moved to placebo ^[9].

• Fast loss may bring hair shedding. A review found more hair-loss reports ^[19], while a skin study linked shedding with quick weight loss ^[20].

• Pregnancy means stopping well ahead of time. Your body needs about five weeks to clear most of the medicine ^[21].

The label requires stopping long before a planned pregnancy. Ask your doctor about the wait that applies to you.

• The pill needs an empty stomach. An added ingredient helps the medicine cross the stomach lining, but only about 0.4-1% of the swallowed drug reaches your blood ^[22].

It’s built to work with that small share. Food, drinks, or another medicine can cut the share further.

• Some pills may need closer checks. Because the stomach empties more slowly, another pill may reach your body later.

A review found few serious clashes from that delay ^[18]. Your doctor or pharmacist can check the pills you take.

This list can’t clear the drug for you. It’ll help you name the risks before treatment and watch for changes later.

Semaglutide side effects most often involve the stomach

Stomach trouble led the study findings. Nausea, constipation, diarrhea, and vomiting were often mild and short ^[13].

Problems came most often while the amount rose. One safety review counted nausea in about one patient out of three ^[5].

That review also found more gallstones. It couldn’t settle the questions about pancreas or thyroid cancer.

SUSTAIN-6 found more eye trouble when blood sugar fell quickly ^[2]. Most affected patients had eye disease before the study.

Reports gathered after FDA approval list much the same set of problems ^[14]. Stomach complaints come first, while other harms stay under watch.

These figures aren’t dose advice. They can’t predict what you’ll feel.

The studies won’t name your side effects in advance. They’ll give you clear questions for your doctor.

Compounded semaglutide lacks the proof behind the factory-made drug

A pharmacist may make compounded Semaglutide for one patient. It isn’t the same product made in an approved factory.

More pharmacies made it during a federal shortage from roughly 2022 into early 2025. That broad access wouldn’t have happened without special shortage rules.

Officials found dose mistakes and harm that sent patients to hospitals. Some products contained ingredients never checked for use as medicine.

In early 2025, officials said the shortage was over. Most pharmacies then lost that broad shortage permission.

The studies on this site used the approved product. Their results don’t cover compounded forms or products sold only for lab work.

We sell nothing and won’t name sellers. You need to know which product you received.

A compounded drug can’t take proof from the factory-made one. Its strength or contents won’t always match the factory-made drug.

FDA uses grew after studies found more kinds of help

Semaglutide came from an older GLP-1 drug, named for the gut hormone it copies. Its makers changed the GLP-1 copy so one shot could last a week.

In 2017, the FDA first approved Semaglutide for type 2 diabetes. The FDA approved a daily pill after that first approval.

In 2021, the FDA approved the drug for long-term weight care ^[21]. In 2023, a heart study found fewer major heart problems ^[3].

In 2024, a kidney study found less major kidney trouble ^[6]. In 2025, the FDA added use for a fatty, swollen liver illness ^[12].

More pharmacies made the drug during the 2022-2025 shortage. Most lost that broad permission when the shortage ended.

These dates can’t say whether Semaglutide fits you. They show when the proof led to new uses.